Sort
39,280 grants matching “leukemia”
Predicting clinical outcome in individuals with small CLL B cell clones
$615,766Tait D Shanafelt · Mayo Clinic Rochester · R01 · FY2015 · CA
Small-molecule MDM2 degraders
$615,748Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Impact of mutational order on molecular mechanisms of oncogenesis
$615,612Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Predicting Relapse at the Time of Diagnosis in Acute Lymphoblastic Leukemia
$615,576Kara Lynn Davis · Stanford University · R01 · FY2021 · CA
Wee1 and HDAC inhibition in relapsed/refractory AML
$615,403Steven Grant · Virginia Commonwealth University · UH2 · FY2017 · TR
Developing Bioinformatic and Microfluidic Single Cell Methods for Studying Intratumoral Heterogeneity in Acute Myeloid Leukemia
$615,257Amy Paguirigan · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Processed Antigen Characterization by Mass Spectrometry
$615,162Donald F Hunt · University Of Virginia · R01 · FY2017 · AI
Outcomes for CLL patients treated with novel therapy
$614,982Neil E Kay · Mayo Clinic Rochester · R01 · FY2023 · CA
Mechanisms of Transformation by TAL1/SCL in Thymic Malignancy
$614,978A Thomas Look · Dana-Farber Cancer Inst · P01 · FY2007 · CA
Small-molecule degraders of STAT5
$614,944Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Genotyping for epidemiology studies
$614,909Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
Modeling and Predicting Therapeutic Resistance of Cancer
$614,899Dean W Felsher · Stanford University · U01 · FY2015 · CA
Modeling and Predicting Therapeutic Resistance of Cancer
$614,898Dean W Felsher · Stanford University · U01 · FY2017 · CA
Project 2: : Systematic discovery of cell-extrinsic mechanisms of cancer drug resistance
$614,870Alex K Shalek · Massachusetts Institute Of Technology · U54 · FY2017 · CA
Clinical Trials Office
$614,853James P Thomas · Ohio State University · P30 · FY2015 · CA
Modeling and Predicting Therapeutic Resistance of Cancer
$614,775Dean W Felsher · Stanford University · U01 · FY2016 · CA
Developing Bioinformatic and Microfluidic Single Cell Methods for Studying Intratumoral Heterogeneity in Acute Myeloid Leukemia
$614,764Amy Paguirigan · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Therapeutic value and mechanistic action of PSPC1 in AML
$614,749Mingjiang Xu · University Of Texas Hlth Science Center · R01 · FY2024 · CA
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation
$614,728Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · DA
Development of ESP: Structural &Functional Oncogenomics
$614,707University Of California San Francisco · R33 · FY2003 · CA
Metabolic Reprogramming in Brain Tumors
$614,680Sabrina Miriam Ronen · University Of California, San Francisco · R01 · FY2017 · CA
O-Glycosylation of Epidermal Growth Factor-like Modules
$614,671Robert S. Haltiwanger · State University New York Stony Brook · R01 · FY2011 · GM
Statistical Informatics for Cancer Research
$614,635Xihong Lin · Harvard School Of Public Health · P01 · FY2012 · CA
A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia
$614,625Austin L Brown · Baylor College Of Medicine · R01 · FY2024 · CA
Novel enhancement of antibody therapy through NOD2 activation
$614,578Susheela Tridandapani · Ohio State University · R01 · FY2025 · CA